Intragraft cytokine gene expression: Implications for clinical transplantation

Transplant International

Volumn 11, Issue 3, 1998, Pages 169-180

  Baan, Carla C ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Expression, intragraft cytokine mRNA; Intragraft cytokine mRNA, expression

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; DNA; MESSENGER RNA;

DNA POLYMORPHISM; GENE EXPRESSION; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; CYTOKINES; GENE EXPRESSION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0031840604     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050124     Document Type: Review

References (105)

1. Adams DH, Hubscher S, Fear J, Johnson J, Shaw S, Afford S (1996) Hepatic expression of macrophage inflammatory protein-1α and macrophage protein-1β after liver transplantation. Transplantation 61: 817-825
2. Aikawa A, McLaughlin PJ, McDicken IW, Davies HM, Southern SA, Johnson PM, Bakran A, Sells RA (1993) TNF staining of graft biopsies in renal transplantation. Transplantation 56: 231-233
3. Ationu A, Carter N (1994) Ventricular expression of basic fibroblast growth factor gene after orthotropic cardiac transplantation. Transplantation 57: 1364-1366
4. Azuma H, Tilney NL (1994) Chronic graft rejection. Curr Opin Immunol 6: 770-776
5. Azzawi M, Hasleton PS, Grant SCD, Stewart JP, Hutchinson IV (1995) Interleukin-10 in human heart transplantation: an in situ hybridization study. J Heart Lung Transplant 14: 519-528
6. Baan CC, Holweg CTJ, Niesters HGM, Van Gelder T, Mol WM, Zondervan PE, Mochtar B, Balk AHMM, Weimar W (in press) The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant
7. Baan CC, Niesters HGM, Metselaar HJ, Mol WM, Zondervan PE, Tilanus HW, IJzermans JMN, Schalm SW, Weimar W (in press) Increased intragraft IL-15 mRNA expression after liver transplantation. Clin Transplant
8. Baan CC, Van Besouw NM, Daane CR, Balk AHMM, Mochtar B, Niesters HGM, Weimar W (1997) Kinetics of IL-2 and IL-4 mRNA and protein production by graft infiltrating lymphocytes responsible for rejection after clinical heart transplantation Transplant Immunol 5: 97-103
9. Baan CC, Metselaar HJ, Mol WM, Tilanus HW, IJzermans JMN, Zondervan PE, Schalm SW, Niesters HGM, Weimar W (1996) Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection. Clin Transplant 10: 542-549
10. Baan CC, Niesters HGM, Balk AHMM, Mochtar B, Zondervan PE, Weimar W (1996) The intragraft cytokine mRNA pattern reflects the efficacy of steroid antirejection therapy. J Heart Lung Transplant 15: 1184-1193
11. Baan CC, Van Emmerik NEM, Balk AHMM, Quint WGV, Mochtar B, Jutte NHPM, Niesters HGM, Weimar W (1994) Cytokine mRNA expression in endomyocardial biopsies during rejection from human heart transplants. Clin Exp Immunol 97: 293-298
12. Billingham ME (1994) Pathology and etiology of chronic rejection of the heart Clin Transplant 8: 289-292
13. Bishop GA, Rokahr KL, Napoli J, McCaughan GW (1993) Intragraft cytokine mRNA levels in human liver allograft rejection analyzed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transplant Immunol 1: 253-261
14. Bolen JB (1995) Protein tyrosine kinases in the initiation of antigen receptor signalling. Curr Opin Immunol 7: 306-311
15. Brazelton TR, Morris RE (1996) Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin). mycophenolate mofetil and leflumide. Curr Opin Immunol 85: 710-720
16. Bugeon L, Cuturi MC, Hallet MM, Paneau J, Chabannes D, Soulillou JP (1992) Peripheral tolerance of an allograft in adult rats. Characterization by low interleukin-2 and interferon-γ mRNA levels by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 54: 219-225
17. Callard RE, Matthews DJ, Hubert L (1996) IL-4 and IL-13 receptors: are they one and the same? Immunol Today 17: 108-110
18. Carter LL, Dutton RW (1996) Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8: 336-342
19. Chen N, Filed EH (1995) Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation 59: 993-941
20. Cozenza CA, Shirwan H, Cramer DV, Sher L, Podesta L, Makowka L (1995) Intragraft cytokine gene expression in human liver allografts. Liver Transplant Surg 1 16-22
21. Crabtree GR (1989) Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355-361
22. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML (1994) Local production of cytokines in the human cardiac allograft. Transplantation 57: 1333-1337
23. Dallman MJ, Roake J, Hughes D, Toogood G, Morris PJ (1992) Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 53: 683-685
24. Dallman MJ, Larsen CP, Morris PJ (1991) Cytokine gene transcription in vascularized organ graft: analysis using semi-quantitative polymerase chain reaction. J Exp Med 174: 493-496
25. Day JD, Rayburn BK, Gaudin PB, Baldwin WM III. Lowenstein CJ, Kasper EK, Baughman KL, Baumgartner WA, Hutchins GM, Hruban RH (1995) Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 14:S142-149
26. Demirci G, Nashan B, Pichlmayr R (1996) Fibrosis in chronic rejection of human liver allografts. Transplantation 62: 1776-1783
27. Devergne O, Marfaing-Koka A, Schall TJ, Leger-Ravet MB, Sadick M, Peuchmaur M, Crevon MC, Kim KJ, Schall TT (1994) Production of RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 179: 1689-1694
28. Gajewski TF, Scheel SR, Tich FW (1990) Evidence implicating utilization of different T cell receptor associated signalling pathways by Th1 and Th2 clones. J Immunol 144: 4110-4120
29. Gaweco AS, Otto G, Geisse T, Hofmann WJ (1995) Distinct intragraft gene expression patterns during acute hepatic rejection under cyclosporin versus FK506 primary immunosuppression. Transplant Proc 26: 3111-3113
30. Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120: 2027-2032
31. Goes N, Urmson J, Ramassar V, Halloran PF (1995) Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation 59: 565-572
32. Gorczynski RM, Adams RB, Levy GA, Chung SW (1996) Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery 120: 496-502
33. Granelli-Piperno A (1990) Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med 20: 533-544
34. Grant SCD, Guy SP, Lamb WR, Brooks NH, Brenchley PEC, Hutchinson IV (1996) Expression of cytokine messenger RNA after heart transplantation. Transplantation 62: 910-916
35. Grimm PC, McKenna RM, Gospodarek EM, Jeffery JR, Rush DN (1995) Low frequency of infiltrating cells intensely expressing T cell cytokine mRNA in human renal allograft rejection. Transplantation 59: 579-584
36. Halloran PF, Bronski AP, Batiuk TD, Madrenas J (1993) The molecular immunology of acute rejection. an overview. Transplant Immunol 1: 3-27
37. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60: 1533-1538
38. Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemström K, Räisänen-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskinen E, Krogerus L, Aho P, Paavonen T (1993) Chronic allograft rejection. Immunol Rev 134: 33-81
39. Iacono A, Dauber J, Keenan R, Spichty K, Cai J, Grgurich W, Burckart G, Smaldone G, Pham S, Ohori NP, Yousem S, Williams P, Griffith B, Zeevi A (1997) Interleukin-6 and interferon-g gene expression in lung transplant recipients with refractory acute cellular rejection. Transplantation 64: 263-269
40. Jain J, Loh C, Rao A (1995) Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 7: 333-342
41. Joseph JV, Guy SP, Brenchley PEC, Parrott NR, Short CD, Johnson RWG, Hutchinson IV (1995) Th1 and Th2 cytokine gene expression in human renal allografts. Transplant Proc 27: 15-16
42. June CH, Bluestone JA, Naudler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15: 321-331
43. Karnitz LM, Abraham RT (1995) Cytokine receptor signalling mechanisms. Curr Opin Immunol 7: 320-326
44. Kirkman RL, Shapiro ME, Carpenter CB, McKay DB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB (1991) A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplantation 51: 107-113
45. Konieczny BT, Saleem SS, Lowry RP, Lakkis FG (1996) Vigorous cardiac and skin allograft rejection in the absence of IFN-γ. J Am Soc Nephrol 7: 1887-1895
46. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJC, Melzer J, Garovoy MR, Roberts JP, Ascher NL, Maninez OM (1992) Cytokine and T-cell receptor gene expression at the site of allograft rejection Transplantation 53:151-156
47. Kusaka S, Grauer AP, Fechner JH, Burlingham WJ (1995) Evidence for a possible TH2 bias in human renal transplant tolerance. Transplant Proc 27: 225-226
48. Lagoo AS, George JF, Naftel DC, Griffin AK, Kirklin JK, Lagoo-Deenadayalan S, Hardy KJ, Savunen T, McGiffin DC (1996) Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. J Heart Lung Transplant 15: 206-217
49. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Buren C, Chou HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438
50. Libby P (1996) Atheroma: more than much. Lancet 348: §4:§7
51. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS (1987) Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 21: 3677-3684
52. Loong CC, Chen A, Lui WY, King KL, Lin CY (1996) Expression of cytokines, growth factors and adhesion molecules in rejecting human renal allograft. Transplant Proc 28: 1445-1446
53. Martinez OM, Krams SM, Sterneck M, Villueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL (1992) Intragraft cytokine profile during human allograft rejection. Transplantation 53: 449-453
54. McLean AG, Hughes D, Welsh KI, Gray DWR, Roake J, Fuggle SV, Morris PJ, Dallman MJ (1997) Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 63: 374-380
55. Merville P, Lambert C, Durand I, Pouteil-Noble C, Touraine JL, Berthoux F, Banchereau J (1995) High frequency of IL-10 secreting CD4 + graft-infiltrating T lymphocytes in promptly rejected kidney allografts. Transplantation 598: 1113-1119
56. Morgan CJ, Pettelier RP, Hernandez CJ, Teske DL, Huang E, Ohye R (1993) Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation 55 919-923
57. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol Today 17: 138-146
58. Mosmann TR, Cherwinski HM, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T-cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357
59. Mottram PL, Räisänen-Sokolowski A, Glysing-Jensen T, Russell ME (1997) Tolerance in IL-4 knockout recipients: primary and secondary graft acceptance occur without Th-2 responses mediated by IL-4 (abstract). Presented at the meeting of the American Society of Transplant Physicians, Chicago, 10-14 May 1997
60. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP (1997) Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 350; 1193-1198
61. Nast CC, Zuo XJ, Prehn J, Danovitch GM, Wilkinsin A, Jordan SC (1994) Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 57: 498-502
62. Nickerson P, Steiger J, Zheng XX, Steele AW, Streureer W, Roy-Chaudhury P, Strom TB (1997) Manipulation of cytokine networks in transplantation. Transplantation 63: 489-494
63. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB (1994) Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 6: 757-764
64. Noronha IL, Eberlein-Gonska M, Hartley B, Stephens S, Cameron JS, Waldherr R (1992) In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies Transplantation 54: 1017-1024
65. Paliogianni F, Boumpas DT (1995) Glucocorticoids regulate calneurin-dependent transactivating pathways for interleukin-2 gene transcription in human T lymphocytes. Transplantation 59: 1333-1339
66. Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM (1996) RANTES chemokine expression in transplant-associated atherosclerosis. J Heart Lung Transplant 15: 1194-1199
67. Pavlakis M, Strelau J, Lipman M, Shapiro M, Maslinski W, Strom TB (1996) Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 62: 543-545
68. Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ, Larsen CP (1996) CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Transplantation 61: 997-1004
69. Piccoti JR, Chan SY, VanBurkirk AM, Eichwald EJ, Bishop DK (1997) Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 635: 619-624
70. Räisänen-Solowski A, Häyry P (1996) Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies. Transplant Immunol 4: 91-98
71. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D (1996) Glucocorticoids promote a Th2 cytokine response by CD4 + T cells in vitro. J Immunol 156: 2406-2412
72. Rao A (1994) NF-ATp: a transcription factor required for co-ordinate induction of several cytokine genes. Immunol Today 15: 274-280
73. Romagnani S (1991) Human Th1 and Th2 subsets: doubt no more. Immunol Today 12: 256-257
74. Roy-Chaudhury P, Manfro RC, Steiger J, Moscovitch-Lopatin M, Strom TB (1997) IL-2 and IL-4 double knock-out mice reject islet allografts: a role for novel T-cell growth factors? Transplant Proc 29: 1083-1084
75. Rudd CE, Janssen O, Cai Y, Da Silva AJ, Raab M, Prasad KVS (1994) Two-step TCRζ/CD3-CD4 and CD28 signals in T-cells: SH1/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 15: 225-234
76. Russell ME, Wallace AF, Hancock WW, Sayengh MH, Adams DH, Sibinga NES, Wyner LR, Karnovsky MJ (1995) Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 59: 572-578
77. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA (1995) CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181:1869-1874
78. Scala G, Oppenheim JJ (1983) Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin-1. J Immunol 131: 1160-1166
79. Schwartz RH (1992) Costimulation of T-lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068
80. Shaddy RE, Hammond EH, Yowell RL (1996) Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol 77: 1210-1215
81. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J, Serur D, Rao V, Suthantriran M (1996) Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy, Kidney Int 49, 1297-1303
82. Sharpe AH (1995) Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout mice'. Curr Opin Immunol 7: 389-395
83. Sibley RK (1994) Morphologic features of chronic rejection in kidney and less commonly transplanted organs. Clin Transplant 8. 293-298
84. Soulillou JP, Cantarovich D, Le Mauff B, Giral M, Robillard N, Hourmant M, Hirn M, Jacques Y (1990) Randomized controlled trial of a monoclonal antibody against the interleukm-2 receptor (33B33.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 322: 1175-1182
85. Steiger J, Nickerson PW, Streurer W, Moscovitch-Lopatin M, Strom TB (1995) IL-2 knockout recipient mice reject islet cell alloarafts. J Immunol 55: 489-498
86. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harman W, Strom TB (1997) Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 94: 695-700
87. Strom TB, Roy-Chaudhury P, Manfro R, Zheng XX, Nickerson PW, Wood K, Bushell A (1996) The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8: 688-693
88. Takeuchi T, Lowry RP, Konieczny B (1992) Heart allografts in murine systems: the differential activation of Th2 like effector cells in peripheral tolerance. Transplantation 53: 1281-1294
89. Thai NL, Fu S, Qian S, Sun H, Gao L, Wang SC, Demetris AJ, Woo J, Thomson AW, Duquesnoy RJ, Fung JJ (1995) Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 59: 274-281
90. Turner DM, Sankaran D, Grant SCD, Yonan N, Sinnott PJ, Dyer PE, Hutchinson IV (1997) Cytokine gene polymorphism and heart transplant rejection Transplantation 64:776-779
91. Turner DM, Grant SCD, Lamb WR, Brenchley PEC, Dyer PA, Sinnott PJ, Hutchinson IV (1995) A genetic marker of high TNF-α production in heart transplant recipients. Transplantation 60. 1113-1117
92. Utans U, Arceci RJ, Yamashita Y, Russell ME (1995) Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allogafts with chronic rejection. J Clin Invest 95: 2954-2962
93. Vacca A, Felli MP, Farina AR. Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A (1992) Glucocorticoid receptor-mediated suppression of the interleukin-2 gene expression through impairment of cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 175: 637-646
94. Van Besouw NM, Daane CR, Vaessen LMB, Mochtar B, Balk AHMM, Weimar W (1997) Donor-specific cytokine production by graft infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allografts. Transplantation 63: 1313-1318
95. Vandenbroeke C, Caillat S, Legendre C, Noel LH, Kreis H, Woodrow D, Bach JF, Tovey MG (1991) Differential in situ expression of cytokines in renal allograft rejection. Transplantation 51: 601-609
96. Van Gelder T, Baan CC, Balk AHMM, Knoop CJ, Holweg CTJ, Van der Meer P, Mochtar B, Zondervan PE, Niesters HGM, Weimar W (1998) Blockade of the IL-2/IL-2 receptor pathway with a monoclonal anti Interleukin-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in man. 65:405-410
97. Van Gelder T, Balk AHMM, Jonkman F, Zietse R, Zondervan PE, Hesse CJ, Vaessen LMB, Mochtar B, Weimar W (1996) A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti interleukin-2 Receptor antibody (BT563) in the prevention of acute rejection after heart transplantation. Transplantation 62: 51-55
98. Van Hoffen E, Van Wichen D, Stuij I, De Jonge N, Klöpping C, Lahpor J, Van Den Tweel J, Gmelig-Meyling F, De Weger R (1996) In situ expression of cytokines in human heart allografts. Am J Pathol 149: 1991-2003
99. Ward SG (1996) CD28: a signalling perspective. J Biochem 318: 361-377
100. Wilson AG, Di Giovine FS, Blakemore AIF, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Molec Genet 1: 353
101. Wu CJ, Lovett M, Wong-Lee J, Moeller MF, Kikaura M, Goralski TJ (1992) Cytokine gene expression in rejection cardiac allografts. Transplantation 54: 326-332
102. Xu GP, Sharma VK, Li B, Bologa R, Li Y, Mouradian J, Wang J, Serur D, Rao V, Stenzel KH, Suthanthiran M (1995) Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection. Kidney Int 48: 1504-1507
103. Zeevi A, Woan M, Yao GZ, Venkataramanan R, Todo S, Starzl TE, Duquesnoy RJ (1991) Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid. bredinin, FK506, cyclosporin, and rapamycin. Transplant Proc 23: 2928-2930
104. Zhao XM, Yeoh TK, First WH, Porterfield DL, Miller GG (1994) Induction of acidic fibroblast growth factor and full-length platelet derived growth factor expression in human cardiac allografts. Circulation 90: 677-685
105. Zhou XM, Yeoh TK, Hiebert M, First WH, Miller GG (1993) The expression of acidic fibroblast factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. Transplantation 56: 1177-1182